Login
| TI Ref No : | 518530435 |
|---|---|
| Description : | Supply Of 82059020: Each Pfs/ Amp/vial Contains Ranibizumab Upto2.3 Mg/0.23ml (the Drug Should Be Dgci Approved For Diabetic Macular Oedema, Retinal Vein Occlusion, Proliferative Diabetic Retinopathy, Retinopathy Of Pre |
| Date : | 2025-05-29 |
| Deadline : | 2025-07-26 |
| Document Type : | Contracts |
